Top Page
NOVONIX Ltd
(Sydney:NVX)
NOVONIX Ltd (NVX) vs. iShares MSCI Australia ETF (EWA)
NOVONIX Ltd Business Overview & Revenue Model
NOVONIX Ltd Financial Statement Overview
| Breakdown | |||||
| TTM | Dec 2024 | Dec 2023 | Dec 2022 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|
| Income Statement | Total Revenue | ||||
| 2.74M | 5.85M | 12.13M | ― | 6.10M | 5.23M | Gross Profit |
| 1.73M | 4.08M | 9.32M | -20.63M | 4.38M | -3.28M | EBIT |
| -46.39M | -51.52M | -45.47M | -39.08M | -47.47M | -15.98M | EBITDA |
| -39.54M | -66.61M | -38.86M | -33.28M | -43.26M | -12.04M | Net Income Common Stockholders |
| -47.64M | -74.82M | -46.25M | -38.08M | -51.86M | -18.08M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
| 494.46K | 42.56M | 78.63M | 73.93M | 142.74M | 136.66M | Total Assets |
| 9.67M | 226.10M | 263.34M | 189.59M | 302.98M | 202.86M | Total Debt |
| 0.00 | 70.42M | 68.22M | 31.34M | 42.31M | 20.01M | Net Debt |
| -494.46K | 27.86M | -10.49M | -42.58M | -100.43M | -116.65M | Total Liabilities |
| 175.09K | 88.51M | 83.74M | 38.20M | 51.85M | 24.68M | Stockholders Equity |
| 9.50M | 137.59M | 183.94M | 151.39M | 251.13M | 178.18M |
| Cash Flow | Free Cash Flow | ||||
| -24.99M | -70.32M | -55.42M | -29.65M | -113.02M | -25.66M | Operating Cash Flow |
| -22.16M | -40.42M | -36.23M | -12.89M | -29.23M | -6.09M | Investing Cash Flow |
| -16.49M | -18.17M | -12.04M | -16.10M | -106.80M | -19.68M | Financing Cash Flow |
| -1.84M | 25.21M | 44.16M | ― | 180.69M | 103.77M |
NOVONIX Ltd Technical Analysis
NOVONIX Ltd Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
64 Neutral | $4.39B | 11.80 | 5.20% | 249.39% | 3.95% | -12.36% | |
48 Neutral | $308.50M | ― | -47.89% | ― | -26.89% | -60.25% | |
| $127.86M | ― | -21.25% | ― | ― | ― | ||
| $119.78M | ― | -17.81% | ― | ― | ― | ||
| $2.08B | 1,408.33 | -36.53% | 7.28% | ― | ― | ||
| $3.04B | 43.31 | -33.95% | 4.54% | ― | ― | ||
| $140.02M | ― | -19.11% | ― | ― | ― |
NOVONIX Ltd Corporate Events
NOVONIX Limited has welcomed the U.S. Department of Commerce’s decision to impose up to 721% tariffs on Chinese synthetic and natural graphite anode material, a move aimed at supporting the U.S. graphite industry and promoting energy independence. This decision, part of a broader investigation into China’s graphite exports, is expected to bolster NOVONIX’s operations, particularly with its plans to expand production capacity in Chattanooga, Tennessee, positioning the company as a significant player in the North American battery materials market.
NOVONIX Ltd has announced the quotation of 29,763 fully paid ordinary securities on the Australian Securities Exchange (ASX) under the code NVX, effective May 13, 2025. This move is part of the company’s ongoing efforts to strengthen its financial position and expand its market presence, potentially impacting its operations and stakeholder interests positively.
NOVONIX Ltd has announced the issuance of 3,635,728 performance rights as part of an employee incentive scheme. This move is aimed at aligning the interests of employees with the company’s strategic goals, potentially enhancing productivity and commitment. The issuance of these unquoted securities reflects NOVONIX’s efforts to strengthen its workforce and maintain a competitive edge in the rapidly evolving battery technology market.
NOVONIX Ltd has made significant strides in its operations, including progressing equipment installation at its Riverside facility to support supply agreements and securing a preliminary ITC trade case ruling for US graphite producers. The company has also entered an exclusive license agreement for graphitization furnaces and received approval for land purchase for a new manufacturing plant. Additionally, NOVONIX has completed a share purchase plan, received substantial reimbursements on the MESC grant, and maintained a strong cash balance, indicating robust financial health and strategic growth initiatives.
NOVONIX Limited has finalized a definitive agreement to purchase a 182-acre parcel in the Enterprise South Industrial Park in Chattanooga, Tennessee, for approximately US$5 million. This site will host NOVONIX’s second facility for high-performance synthetic graphite, expected to create 450 to 500 full-time jobs and increase the company’s total production capacity in Chattanooga to over 50,000 tonnes per annum. The acquisition is part of NOVONIX’s expansion strategy, supported by local government endorsements and contingent on a US$754 million loan from the U.S. Department of Energy. Additionally, NOVONIX is enhancing its collaboration with local educational institutions to provide career-focused learning opportunities in the battery industry.
NOVONIX Ltd has announced a change in the director’s interest, with Anthony Bellas acquiring 120,594 share rights, valued at approximately $53,664. This change reflects the company’s ongoing efforts to align its leadership’s interests with its strategic goals, potentially impacting its market positioning and stakeholder confidence.
NOVONIX Ltd announced a change in the director’s interest, with Jean Oelwang acquiring 120,594 share rights, valued at approximately $53,664 based on the closing share price on April 28, 2025. This change reflects a strategic move in the company’s governance, potentially impacting its market positioning and signaling confidence in its future prospects.
NOVONIX Ltd has announced a change in the director’s interest notice, specifically regarding Sharan Burrow. The director has acquired 120,594 share rights, valued at approximately $53,664 based on the closing share price on April 28, 2025. This change reflects an increase in the director’s holdings, which may impact the company’s governance and stakeholder confidence.
NOVONIX Ltd has announced a change in the director’s interest notice, specifically regarding Ron Edmonds, who has acquired 241,188 share rights. This change reflects an estimated value of $107,329 based on the closing share price on April 28, 2025. The update could potentially impact the company’s governance and investor perception, as it indicates confidence in the company’s future performance and strategic direction.
NOVONIX Ltd announced a change in the director’s interest, with Robert Natter acquiring 120,594 share rights directly, valued at approximately $53,664. This change reflects the company’s ongoing commitment to aligning its leadership’s interests with its strategic goals, potentially impacting its market positioning and stakeholder confidence.
NOVONIX Ltd announced the issuance of 1,008,567 unquoted share rights, marking a strategic move to bolster its equity base. This development is significant for the company’s financial structuring and could enhance its market positioning by potentially attracting more investors and stakeholders interested in the growing battery materials sector.
NOVONIX Limited has announced the appointment of Michael O’Kronley as its new Chief Executive Officer, effective May 19, 2025. Mr. O’Kronley, who brings over 30 years of experience in the automotive and lithium-ion battery sectors, is expected to lead the company into its next growth phase, focusing on onshoring the graphite supply chain in North America. His appointment follows the interim leadership of Mr. Robert Long, who will return to his role as Chief Financial Officer. This leadership change is seen as a strategic move to strengthen NOVONIX’s position in the battery technology industry and enhance its operational capabilities.
NOVONIX Ltd has announced the issuance of 7,758,413 unquoted performance rights as part of its employee incentive scheme. This move is indicative of the company’s strategy to align employee interests with corporate goals, potentially enhancing productivity and commitment. The issuance of these securities reflects NOVONIX’s ongoing efforts to strengthen its operational framework and maintain a competitive edge in the rapidly evolving battery technology industry.
NOVONIX Ltd has announced the quotation of 15,414 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of March 31, 2025. This move is part of the company’s strategy to enhance its market presence and provide additional liquidity for its stakeholders, reflecting its ongoing commitment to growth and expansion in the competitive battery technology industry.
NOVONIX Ltd announced a change in the director’s interest, with Nicholas Liveris disposing of 500,000 ordinary shares through an on-market trade, reducing his holding to 894,681 shares. This transaction, valued at $221,780, reflects a significant shift in the director’s investment, potentially impacting the company’s stock market perception and investor confidence.
NOVONIX Ltd has announced the quotation of 6,347 fully paid ordinary securities on the ASX, effective March 14, 2025. This move is part of the company’s strategy to enhance its market presence and operational capabilities, potentially impacting its stakeholders by increasing liquidity and investor interest.
NOVONIX Limited has received unanimous approval from the City of Chattanooga and Hamilton County to purchase a 182-acre parcel of land for its second mass production plant, Enterprise South, in Chattanooga, Tennessee. This facility is expected to reach full production capacity by 2028, creating 500 jobs and increasing the company’s total production capacity to over 50,000 tonnes per annum. The expansion aligns with NOVONIX’s strategic growth plans and commitment to local workforce development, further solidifying its presence in the battery materials industry. The company has also secured significant financial support from the U.S. Department of Energy and has binding agreements with major companies like Panasonic Energy, Stellantis, and PowerCo, highlighting its strong market positioning and future growth potential.
NOVONIX Ltd has announced a change in the director’s interest, with Anthony Bellas acquiring 109,749 ordinary shares directly, replacing an equivalent number of share rights. This change reflects a strategic move in the company’s executive shareholding structure, potentially impacting investor perceptions and stakeholder confidence in the company’s governance and future direction.
NOVONIX Ltd has announced a change in the director’s interest, specifically for Jean Oelwang, who has converted 109,749 share rights into ordinary shares. This change increases Oelwang’s total holdings to 188,914 ordinary shares, reflecting a strategic adjustment in the director’s investment portfolio.
NOVONIX Ltd announced a change in the director’s interest, with Sharan Burrow converting 84,145 share rights into ordinary shares. This transaction reflects the vesting of share rights, valued at approximately $35,341, indicating a strategic alignment with the company’s equity structure and potentially impacting shareholder value.
NOVONIX Ltd has announced a change in the director’s interest, with Ron Edmonds converting 109,749 share rights into ordinary shares, increasing his total holdings to 175,154 ordinary shares. This change reflects the vesting of share rights and indicates a strategic alignment of the director’s interests with the company’s long-term growth objectives, potentially impacting shareholder confidence and market perception.
NOVONIX Ltd announced a change in the director’s interest, specifically involving Robert Natter. The change involves the conversion of 109,749 share rights into ordinary shares, increasing his direct holding to 988,025 ordinary shares. This move reflects the company’s ongoing efforts to align its leadership’s interests with shareholder value, potentially impacting investor confidence and market perception positively.
NOVONIX Limited has announced its Annual General Meeting (AGM) for 2025, which will be conducted as a hybrid event, allowing shareholders to participate both online and in person. The agenda includes reviewing financial statements, considering the remuneration report, and voting on the election and re-election of directors. Additionally, shareholders will vote on the issuance of share rights to certain directors, which could impact the company’s governance and compensation structure.
NOVONIX Ltd has announced the quotation of 3,070 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of March 3, 2025. This move is part of the company’s strategy to enhance its market presence and provide more liquidity to its shareholders, potentially strengthening its position in the competitive battery materials industry.
NOVONIX Ltd has released its Corporate Governance Statement for the year ended 31 December 2024, emphasizing its commitment to governance best practices. The statement outlines the company’s adherence to the ASX Corporate Governance Principles, detailing policies on board management, director appointments, and diversity objectives. This governance framework is designed to support the company’s strategic objectives and enhance shareholder value, with a focus on transparency and accountability.